Incorporation of BRCA1 testing into prenatal carrier screening for hereditary breast and ovarian cancer prevention should take carrier rates into account
Am J Obstet Gynecol. 2024 Dec 11:S0002-9378(24)01181-5.
doi: 10.1016/j.ajog.2024.12.004.
Online ahead of print.